A global network promoting objective and open debate on drug policy
Cookie policy
We use cookies to ensure we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the IDPC website. Otherwise you can change your cookie settings here.
The bill needs to make it clear that its objective is to promote harm-reduction and health, as well as the decriminalisation of drug possesion for personal use.
The HCLU attended CND 2013 annual meeting in Vienna and interviewed key professionals that talked about the new approach of New Zealand to new psychoactive drugs, the views of UNOCD to the legalization of marijuana in the US and the new marijuana regulation scheme of Uruguay.
The introduction of the Psychoactive Substances Bill is a comprehensive and thoughtful response to what is proving to be one of the biggest challenges to drug policy makers around the world.
New Zealand’s Associate Minister of Health Peter Dunne has announced a new system for regulating synthetic highs. Due to come into effect next year, the regime places the onus on the legal high industry to prove their products are safe before they go on sale.
Experts from around New Zealand, and from overseas, will gather in Wellington on Tuesday 30 August for a Drug Policy Symposium organised by NZ Drug Foundation and NZ Society on Alcohol and Drug Dependence.
The New Zealand Drug Foundation has produced a short video from an interview with the authors of the review of New Zealand's 35-year-old Misuse of Drugs Act. The video can be visualised online via the following link: http://vimeo.com/9643269.
This survey conducted by the New Zealand Drug Foundation asseses knowledge, attitudes and behaviours around driving under the influence of psychoactive substances, including illicit drugs, prescription medicines, and alcohol in New Zealand.
